Type 1 and Covid-19: Diagnosis, Clinical Care, and Health Outcomes during the Pandemic - 23/01/24
, Mary Pat Gallagher, MDRésumé |
The coronavirus disease 2019 (COVID-19) pandemic disrupted health care, creating challenges for people with diabetes and health care systems. Diabetes was recognized as a risk factor for severe disease early in the pandemic. Subsequently, risk factors specific for people with type 1 diabetes were identified, including age, hemoglobin A1c level, and lack of continuous glucose monitoring . Telemedicine, especially when accompanied by diabetes data, allowed effective remote care delivery. However, pre-existing racial disparities in access to diabetes technology persisted and were associated with worse outcomes. Events of the COVID-19 pandemic underscore the importance of continuing to develop flexible and more equitable health care delivery systems.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19 telehealth, Type 1 diabetes disparities, Diabetes technology pandemic, Remote monitoring health care delivery
Plan
Vol 53 - N° 1
P. 135-149 - mars 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
